ADAMA (000553) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
2 Sep, 2026Executive summary
Achieved first year-over-year quarterly sales growth since Q3 2022, with Q2 2025 sales up 5% to $1,092M and H1 2025 sales stable at $2,091M; EBITDA and margin growth continued, marking the fifth consecutive quarter of improved profitability.
Adjusted net income turned positive in both Q2 ($6M) and H1 ($49M), reversing prior year losses; net loss narrowed significantly year-over-year.
Transformation strategy, Fight Forward, focused on cost reduction, operational efficiency, and portfolio quality, is delivering results.
Volume growth offset price declines, with notable regional differences in performance.
Gross margin and EBITDA margin improved significantly, reflecting operational efficiency and cost control.
Financial highlights
Q2 2025 sales reached $1,092M, up 5% year-over-year; H1 2025 sales stable at $2,091M.
Q2 adjusted gross profit rose 18% to $318M (29.1% margin); adjusted EBITDA up 25% to $150M (13.7% margin).
H1 adjusted gross profit up 11% to $620M (29.7% margin); adjusted EBITDA up 23% to $310M (14.8% margin).
Free cash flow for H1 increased to $90M from $51M last year.
Adjusted net profit for H1 was $49M, reversing losses from H1 2024.
Outlook and guidance
Market remains under price pressure due to Chinese overcapacity and weak farmer economics.
Channel inventory normalization is supporting volume recovery, but price declines persist.
Management remains committed to sustainable growth through innovation, operational agility, and commercial excellence.
Latest events from ADAMA
- Net profit rebounded to RMB 432.6 million as margins improved despite revenue decline.000553
Q2 2026 - Q1 2026 sales and net profit rose, while EBITDA declined amid higher costs and price pressures.000553
Q1 2026 - EBITDA rose 25% in 2025 despite a 2% sales drop, with strong cash flow and improved margins.000553
Q4 2025 - Sales and margins improved, with net loss narrowing and operational efficiency gains achieved.000553
Q3 2025 - Margins and cash flow improved in Q3 2024 despite lower sales and ongoing pricing pressure.000553
Q3 2024 - Sales fell 16% in H1 2024, but margins and cash flow improved through cost discipline.000553
Q2 2024 - Net profit rebounded and EBITDA rose 21% as margins and cash flow improved despite lower sales.000553
Q1 2025 - Gross and EBITDA margins rose in 2024, with strong cash flow despite lower sales.000553
Q4 2024